News
 International
 National
 Embassy News
 Arts & Living
 Business
 Travel & Hotel
 Medical Tourism New
 Taekwondo
 Media
 Letters to Editor
 Photo Gallery
 News Media Link
 TV Schedule Link
 News English
 Life
 Hospitals & Clinics
 Flea Market
 Moving & Packaging
 Religious Service
 Korean Classes
 Korean Weather
 Housing
 Real Estate
 Home Stay
 Room Mate
 Job
 English Teaching
 Translation/Writing
 Job Offered/Wanted
 Business
 Hotel Lounge
 Foreign Exchanges
 Korean Stock
 Business Center
 PR & Ads
 Entertainment
 Arts & Performances
 Restaurants & Bars
 Tour & Travel
 Shopping Guide
 Community
 Foreign Missions
 Community Groups
 PenPal/Friendship
 Volunteers
 Foreign Workers
 Useful Services
 ST Banner Exchange
  Medical Tourism
Asthma Medicines Still Unaffordable for Many
Special Contribution
By Shobha Shukla
Woman suffering from asthma

Globally around 300 million people suffer from asthma, yet for many of them living in low- and middle-income countries access to quality-assured, affordable asthma essential medicines still remains a distant dream. This was revealed in a study conducted by Dr Zaheer Babar from the School of Pharmacy at the University of Auckland and Dr Karen Bissell from the University¡¯s School of Population Health and International Union Against Tuberculosis and Lung Disease (The Union), and published in the journal PharmacoEconomics.

The study investigated the availability, pricing and affordability of the three main asthma medicines (beclometasone, budesonide and salbutamol) which are on the World Health Organisation¡¯s (WHO¡¯s) Model List of Essential Medicines - in 52 selected low- and middle-income countries. It found that essential asthma medicines are still largely unavailable and unaffordable for most in low-income countries.

"The provision of affordable essential medicines is one of the United Nations Millennium Development Goals, but there are millions of people suffering from asthma in low and middle income countries who cannot access the essential asthma medicines recommended by the WHO. The medicines are either not available, or if they are available, they are so expensive that people cannot afford to buy them," said Dr Babar to Citizen News Service (CNS).

The study used as benchmarks the international reference prices (IRPs) generated by Management Sciences for Health, and the 2011 prices of the Asthma Drug Facility (ADF), which were lower than the IRPs. Data collected as part of the study from private retail pharmacies, national procurement centres and public hospitals found a considerable variability in pricing and affordability across countries. Availability for inhaled corticosteroids was particularly poor, and worse in national procurement centres and main hospitals. Many national Essential Medicines Lists (EMLs) had not been updated to incorporate inhaled corticosteroids.

According to Dr Bissell, "Poor availability of inhaled corticosteroids is a serious matter, because under-use of inhaled corticosteroids results in poor asthma control, frequent unplanned visits to the emergency room, more hospitalisations and an unnecessary reduction in quality of life for those who live with asthma."

Then again, the surveyed strength of beclometasone was on the EML of only 10 of the surveyed countries. Procurement systems appeared largely inefficient when ADF prices were applied as references. Some countries seemed to be subsidising asthma medicines, making them free or less expensive for patients, while others were applying very high margins, which can significantly increase the price for patients unless a reimbursement system exists.

Procurement of generic medicines is generally expected to result in cost saving and improved affordability. In the majority of cases the prices for innovator brand medicines were found to be higher than for the generic medicines. But in India and Kenya the price of innovator brand salbutamol in private retail pharmacies was less than the generic medicine.

The study¡¯s findings raise important policy concerns— availability of inhaled corticosteroids is poor; many EMLs are not updated; IRPs can be misleading; health systems and patients are paying more than necessary for asthma medicines, which are unaffordable for many patients in many countries. Professor Innes Asher, Chair of the Global Asthma Network, lamented that, "This study proves that people in low- and middle-income countries are not benefiting from the essential asthma medicines they need, to control their asthma and lead active, productive lives. International and national efforts to address Non Communicable Diseases (NCDs) will be futile unless we urgently address issues of availability, affordability and quality of the essential medicines and technologies required to treat and manage NCDs such as asthma".

The Global Asthma Network has rightly called for action from the global NCD movement for asthma to be properly recognised as a major chronic NCD, and for global NCD policy, strategy and funding to give due priority to resolving problems of access to essential medicines for asthma and other major NCDs. Professor Asher will also be giving a plenary lecture on 'Asthma: the forgotten epidemic?' at the forthcoming 44th Union World Conference on Lung Health in Paris, to connect the dots and focus attention around this debilitating yet often neglected disease. (CNS)

Shobha Shukla, Citizen News Service – CNS



Related Articles
    Are We Putting Money Where the Mouth Is to ...
    Early and Accurate TB Diagnosis Is the Gateway ...
    Long Walk to Transgender Rights and Gender ...
    Strong Local Actions Are Pivotal to Reduce ...
    The Head Must Follow What the Hand Writes
    Ending Tobacco Smoking Is Bedrock for ...
    Asia Pacific Has over 6.7 Million New TB Cases
    Will Shorter, Safer and More Effective TB ...
    Whither Women's Reproductive Health in Asia ...
    Build the World We Want: Healthy Future for All
    New TB Treatment Breakthroughs Must Reach the ...
    How Will Children Living with HIV Grow Up ...
    Writing Is on the Wall: Pictorial Health ...
    Failing on the Basics: Are We Able to Break ...
    A Bouquet of Novel Compounds: New Treatment ...
    One Size Does Not Fit All: Expanding the ...
    Tale of Two Pandemics: Follow the Science and ...
    Governments Must Adopt a Strong Political ...
    What Is the Ring?
    Disability Is Not Limited to the Body, It Is ...
    Accelerating Progress on Sexual & Reproductive ...
    Stop This Shaming of Menstruation
    Complacency Breeds Failure: Consolidate ...
    For Age Is Opportunity No Less Than Youth ...
    New Study Pegs the Number of TB Cases in India ...
    Self-stigma: Let Us Do More Than Just "Ttalk ...
    We Cannot Eliminate TB If We Leave Children ...
    MDR-TB Treatment Rgimen: Short Indeed Is ...
    A Plain Face Can Take the Sheen Out of Deadly ...
    Strike at the Root of the Problem to Kill TB
    Antibiotic Use Is Driving Antibiotic Resistance
    Big Push for Transgender and Hijra Welfare
    Where There Is a Will There Is a Way: Teeja ...
    Lung Cancer: Difficult to Diagnose, Difficult ...
    Long Road to Justice: Human Rights of Female ...
    Medical Malpractices: Is There Light at the ...
    Overcoming Roadblocks in Translating ...
    Management of Respiratory Diseases beyond ...
    Gender Justice to Be at the Heart of ...
    Connecting the Dots: Tobacco Use, Diabetes, ...
    It Is Time To Control Asthma
    Call for No More New HIV Infected Children
    Smoking Goes Electronic
    Break the Silence around Cancer
    How Can You Treat Your Illness Unless You Take ...
    New Technique to Prevent Diabetic Lower-Limb ...
    Cycle Beads: The Bead String for Family ...
    Beware: All Forms of Tobacco Are Harmful!
    Mother's Milk Is the Best Nutrition for the ...
    Where Is The TB Quilt, Nay Mask?
    Hello, This Is Nature¡¯s Call From Garbage ...
    Tuberculosis: Ugly Scar on Beautiful Childhood
    Towards A More Enabling Environment for ...
    What¡¯s Cooking in Kitchen: Peace or Conflict?
    Feed Your Child Well: Prevent Pneumonia
    Costly Medicines Mean Debt or Death for People ...
    AIDS Epidemic at a Critical Juncture in ...
    Watch Your Tongue Mr. Minister!
    Free Trade Agreements: A Threat To People's ...
    In The Pursuit Of Healthy Happiness
    Empowering Rural Women
    Say Yes To Life: Say No To Tobacco
    Homophobia Is A Human Rights Issue
    Viva La Woman Power
    Rubbish Rubbish Food and Embrace Healthy ...
    Of Music and Divinity
    Wake Up Call on Childhood Obesity after Years ...
    A New Hope of Life for Our Ailing Education ...
    Reminiscences of Egypt
    Do Not Break the Nucleus
    Whispers of Sanity in the Frenzy of Madness
    Tobacco Cessation Can Piggy-back Ride on ...
    In The Spirit Of Freedom (from Tobacco)
    World Conference on Tobacco or Health to ...
    Requiem for Purity
    Rhapsody 2008 -- a Symphony of Different ...
    'Diabetes Doctor Is at Your Doorstep' in ...
    Activists Decry India's Deferment of Pictorial ...
    South-East Asian Diabetes Summit to Open Up in ...
    Special on Universal Children's Day
    The Wrath Of God
    World Food Scarcity and the Challenges of ...
    Victim of Terrorism -- the Common Man
    Teachers' Day: The Sacrificial Goat
    Hiroshima Day: Let Us Worship Peace and Shun ...
    Whither the Innocence of Childhood?
    Food for Thought -- on World Food Day
    Love Is the Missing Link in War-on-Terror
    Irom Sharmila: The Iron Lady
    India Poised And Shining
    Is It Just Another Day in Life of Indian Woman?
    He Has His Cake and Eats It Too
    To Be Young, to Be Married, and to Be in India
    The Mad Mad World of Ads

Other Articles by Shobha Shukla
    Early and Accurate TB Diagnosis Is the ...
    Strong Local Actions Are Pivotal to Reduce ...
    The Head Must Follow What the Hand Writes
    Ending Tobacco Smoking Is Bedrock for ...
    Asia Pacific Has over 6.7 Million New TB ...


Ms. Shobha Shukla has been teaching Physics at India's noted Loreto Convent, and has written for The Hindustan Times and Women's Era in the past. She serves as Editor of Citizen News Service (CNS). She can be contacted at shobha1shukla@yahoo.co.in)

 

back

 

 

 

The Seoul Times, Shinheung-ro 36ga-gil 24-4, Yongsan-gu, Seoul, Korea 04337 (ZC)
Office: 82-10-6606-6188 Email:seoultimes@gmail.com
Copyrights 2000 The Seoul Times Company  ST Banner Exchange